VICTORIA GROSS: Open Payments
NPI 1477221968 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 153 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,786 · 2025 $2,639
Food & beverage: $2,639
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $683 |
| Madrigal Pharmaceuticals | 11 | $303 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $285 |
| Phathom Pharmaceuticals, Inc. | 20 | $264 |
| QOL Medical, LLC | 10 | $261 |
| Janssen Biotech, Inc. | 24 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $199 |
| GENZYME CORPORATION | 9 | $141 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
Products named: RINVOQ, REZDIFFRA, XIFAXAN, VOQUEZNA, Sucraid, TREMFYA, DUPIXENT, ENTYVIO.
Industry payments across KY — which companies pay providers there.
